Jury Finds Illumina Infringed LadaTech DNA Patent
Illumina Inc.'s DNA sequencing products infringe a LadaTech LLC patent related to genome analysis technology, a Delaware federal jury ruled Tuesday, rejecting Illumina's claims that the patent is invalid due to...To view the full article, register now.
Already a subscriber? Click here to view full article